Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Myo-Inositol wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
7 of 11 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
5 of 10 studies with measurable effects showed benefit.
Top outcomes
120-240mg standardized extract
With meals, Split into 2-3 doses
Standardized extract capsules (EGb 761)
2-4g daily for PCOS; up to 12-18g for anxiety
Divided doses with meals, Morning and evening
Myo-inositol powder
4-6 weeks
4-8 weeks
First week
3-6 months
4-6 weeks
2-3 months
Initial use or high doses
Can We Use Ginkgo biloba Extract to Treat Alzheimer's Disease? Lessons from Preclinical and Clinical Studies
Cells (2022) · Meta analysis · n=2100
GBE was shown to reduce the escape latencies in several studies, in both rats and mice (I2 > 70%, p < 0.005).
Beneficial effects of Ginkgo biloba leaf extract on inflammatory markers: A systematic review and meta-analysis of the clinical trials
Phytotherapy research : PTR (2022) · Meta analysis · n=1104
In the meta-analysis, the weighted mean differences (WMD) in change for serum CRP were -1.5 mg/L (95% CI: -2.16, -0.85, p < 0.001).
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia
The Cochrane database of systematic reviews (2018) · Meta analysis · n=1278
Studies were primarily of short (three to six6 weeks) duration with small samples size (10 to 157 participants), and most (61%) were published more than 20 years ago.
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
The Cochrane database of systematic reviews (2023) · Meta analysis · n=1319
For the primary neonatal outcomes, only one study measured the risk of a large-for-gestational-age infant and found myo-inositol was associated with both appreciable benefit and harm (RR 1.40, 95% CI 0.65 to 3.02; 1 study, 234 infants; low-certainty evidence).
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=1321
Pooled results were expressed as relative risk (RR) or mean difference (MD) with a 95% confidence interval (95% CI).
Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials
European review for medical and pharmacological sciences (2022) · Meta analysis · n=612
Compared with metformin, the suitable supplemental dosage of myo-ins may be helpful in lowering levels of TG and avoiding adverse events (AEs).
Based on multiple meta-analyses including 2100+ participants showing benefits in mild dementia and memory. Effects modest and primarily in older adults or those with existing cognitive decline. Standardized extract (EGb 761) preferred.
Based on multiple meta-analyses showing improved menstrual regularity and ovulation in PCOS. Evidence quality varies across studies with some showing minimal differences vs placebo. 4g daily most commonly studied dose.
AI-estimated from published studies. Interpret as directional guidance.
Myo-Inositol has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For pms relief, Ginkgo Biloba has a higher relevance score (72 vs 70).
No known interactions between Ginkgo Biloba and Myo-Inositol have been documented in our database. However, always consult a healthcare provider before combining supplements.